Nasopharyngeal Carcinoma พ.ท. ขจรเกียรติ ประสิ ทธิเวชชากูร Epidermiology Incidence • Rare neoplasm in most parts of world • Higher incidence in Chinease & Taiwan • Chinease gene increase incidence of NPC • Age > 40 years Incidence • Emigration from high incidence to low incidence area reduces incidence of NPC • Male : female = 3:1 Risk factor • Genetic maker of NPC HLA-A2 found in Chinease population ) • • • • • EB-virus Nitrosamines Polycyclic hydrocarbons Chronic nasal sinus infection Poor hygiene ( Anatomy Pathology Pathology • The most common is squamous cell carcinoma • Most common position is Rosenmuller fossa • Mass lesion – exophytic mass – Ulcerative mass – Infiltrative mass Histopathology Histopathology • Base on predominant histologic type • WHO type 1 : Squamous cell carcinoma nonkeratizing • WHO type 2 : Trasitional cell carcinoma Histopathology • WHO type 3 : Undifferentiated carcimomas – Lymphoepitheliomas – Anaplastic carcinomas WHO type 1 • Squamous cell carcinoma nonkeratizing – Strong intracellular bridges – Less keratin production • Less associate EBV • 25% of case • Radioresistant tumor WHO type 2 • • • • • Trasitional cell carcinoma Not produce keratin Greater degree of tumor pleomorphism Most common is papillary morphology 12% of case WHO type 3 • Undifferentiated carcimomas • Lymphoepitheliomas, Anaplastic carcinomas, Clear cell carcinoma, Spindle cell carcinoma • Most common cell type of NPC • Clear nucleus • 63% aggressive behavior • Radiosensitive Tumor Spreading Local invasion • Anterior : involve hard palate, medial pterygoid plate, ethmoid & maxillary sinus • Lateral : involve internal jugular V, internal carotid A, CN IX X XI XII, Local invasion • Medial : Eustachian tube involvement, mastoid air cell • Superior : involve base of skull, throught foramen lacerum & cavernous sinus • Inferior : oropharynx & soft palate Lymphatic spreading • Most common is neck node spreading • Bilateral involvement • Most common position is upper jugular node • Least at submandibular & submental node Distance metastasis • Most common is – Bone – Lung – Liver • Other sites are rare Clinical Manifestation Clinical Manifestation • Related to location of primary tumor & course of disease • Most common complaint is Hearing loss & lump in the neck Neck mass • Most common spread to neck lymph node • Complaint neck mass • Bilateral metastasis to lymph node is common Neck mass • Most common location is Upper jugular node ( compose of jugular node, spinal accessory node ) • retropharyngeal node induce headache Frequency of lymph node manifestration • • • • Upper jugular region Posterior cervical group Middle & lower jugular group Supraclavicular group Nasal cavity involvement • Blood-tinge anterior or posteriornasal drainage • Obstruction of nasal pathway • Epistaxis • Halithosis • Nasal congest Ear involvement • Result from eustachian tube involvement • Sensation of ear blockage • Serous otitis media • Conductive hearing loss • Tinitus Neurologic involvement • Cranial nerve involvement found 25 28% • Pain in the neck, facial pain, facial pareathesia ( CN V ) • Diplopia ( CN VI ) Neurologic involvement • CN III & IV late phase • CN VII & VIII less involvement • CN IX, X & XI can be found Clinical Manifestation • Neck lump 60% • Ear (s) plugging & fullness 41% • Hearing loss 37% • Nasal bleeding 30% • Nasal obstruction 29% • Head pain 16% • Ear pain 14% • Neck pain 13% • Weight loss 10% • Diplopia 8% Symptom & sign of NPC frequency at diagnostic in Mayo clinic series Kuala Lumpur 1983, University of Malaya Clinical Manifestation • • • • • • • • • • Neck mass Headache Ear pain Nasal obstruction, bloody discharge Facial pareathesia Dysphagia Diplopia, strabismus Facial pain, eye pain Halithosis Exopthalmos 68% 58% 52% 48% 22% 16% 14% 12% 12% 2% Symptom from NPC found in Siriraj hospital 2532 Other sign & symptom • • • • • Weight Anorexia low grade fever Trismus Nasal regurgitation of fluid Diagnostic Evaluation Clinical evaluation • • • • History taking Physical examination Nasopharyngoscopy Endoscopic nasopharyngoscopy Radiologic evaluation • Plain film head & neck • CT scan head & neck ( for evaluation & treatment planning ) • MRI ( if intracranial extension ) Histopathologic evaluation • Biopsy • Most common site are roof of nasophalynx & Rosenmuller fossa Immunology • Indirect immunofluorescence for IgG & IgA antibodies to viral capsid antigen (VCA) & early antigen (EA) – Most specific test for diagnosis – Highly predictive of the clinical course – not yet commercially available Immunology • Antibody-dependent cellular cytotoxicity ( ADCC ) – Often predict the clinical course of WHO type 2&3 Clinical Staging Clinical Staging • T classification – Tis carcinoma in situ – T1 tumor confine in one site of nasopharynx no tumor visible – T2 tumor involve 2 site – T3 extension of tumor into nasal cavity or oropharynx – T4 tumor invasion of skull or cranial involvement Clinical Staging • N Classification – Nx node cannot be assessed – N0 no regional lymph node positive – N1 single ipsilateral lymph node size < 3 cm. Clinical Staging – N2a single ipsilateral lymph node size 3 - 6 cm. – N2b multiple ipsilateral lypmh node size < 6 cm. – N2c bilateral or contralateral lymph node size < 6 cm. – N3 lymph node size > 6 cm. Clinical Staging • M classification – Mx – M0 – M1 not assessed no distance metastasis distance metastasis present Stage grouping • Stage I • Stage II • Stage III • Stage IV T1 T2 T3 T<3 T4 any T any T N0 N0 N0 N1 N<1 N 2-3 any N M0 M0 M0 M0 M0 M0 M1 Treatment Radiotherapy • The most proper treatment • 60 - 70 Gy for 6 - 7 weeks • 75 Gy if present brain involvement Radiotherapy • Complication – Dental caries – Otitis media & otitis externa – Trismus Chemotherapy • Control distance metastasis • Complication – Hair loss – Nausea & vomitting – Weight loss – Anorexia Surgery • Lymph node present after radiotherapy 4 - 6 weeks • Recurrent lymph node enlargement Prognosis Prognosis • 5 years survival ( A.C. 1965 ) – Stage I – Stage II 44% 30% • Radiotherapy + Chemotherapy good result ^_^ Thank You ^_^